ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft function"

  • 2021 American Transplant Congress

    Indocyanine Green Fluorescence Imaging Allows Quantification of Ischemic Injury During Porcine Normothermic Ex Situ Perfusion

    T. Goto, Y. Noguchi, S. Ganesh, L. Mazilescu, T. Reichman, N. Selzner, M. Selzner

    Ajmera Transplant Program, Department of Surgery, Toronto General Hospital, Toronto, ON, Canada

    *Purpose: Normothermic Ex Situ Liver Perfusion (NEsLP) is a novel preservation technique for the storage and assessment of grafts retrieved after Donation after Cardio-circulatory Death…
  • 2021 American Transplant Congress

    Hypoperfusion Warm Ischaemia Time in Renal Transplants from Donors After Circulatory Death

    I. D. Kostakis1, T. Kassimatis1, C. Flach2, N. Karydis1, N. Kessaris1, I. Loukopoulos1

    1Department of Transplantation, Guy’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom, 2School of Population Health and Environmental Studies, King’s College London, London, United Kingdom

    *Purpose: Donor hypoperfusion before asystole in renal transplants from donors after circulatory death (DCD) has been considered responsible for worse outcomes than those from donors…
  • 2021 American Transplant Congress

    Impact of Liver Acuity Circles on Timing of Donor Procurements

    R. Radhakrishnan, D. Goldberg

    University of Miami, Miami, FL

    *Purpose: The Acuity Circles (AC) policy in liver transplantation led to broader organ sharing, whereby many organ procurement organization (OPOs) had to coordinate organ offers…
  • 2020 American Transplant Congress

    The Impact of Occult Graft Fibrosis on Clinical Outcomes in Human Liver Transplant Recipients

    H. Hirao1, T. Ito1, B. V. Naini1, K. Nakamura2, S. Kageyama1, K. Kadono1, H. Kojima1, K. J. Dery1, S. Younan1, F. M. Kaldas1, R. W. Busuttil1, J. W. Kupiec-Weglinski1

    1UCLA, Los Angeles, CA, 2Kyoto University, Kyoto, Japan

    *Purpose: Although liver transplantation (LT) has become a standard therapy for end-stage liver disease, early allograft dysfunction (EAD) and graft rejection remain serious unsolved problems.…
  • 2020 American Transplant Congress

    Normothermic Machine Perfusion of Extended Criteria Donor Livers: Identification of Protein Biomarkers Predictive of Graft Viability and Post-Transplant Complications

    L. L. Wallace1, J. Attard1, Y. Boteon1, R. Laing1, J. Yu2, T. Perera3, D. Mirza3, H. Mergental3, S. Afford1

    1Centre for Liver and Gastrointestinal Research, University of Birmingham and the NIHR Biomedical Research Centre, UHB NHS Foundation Trust, Birmingham, United Kingdom, 2School of Biosciences, Advanced Mass Spectrometry Facility, University of Birmingham, Birmingham, United Kingdom, 3Liver Unit, The Queen Elizabeth Hospital, Birmingham, United Kingdom

    *Purpose: The Viability Testing and Transplantation of mArginal donor Livers Clinical Trial (VITTAL) demonstrated the capacity of Normothermic Machine Perfusion (NMP) to increase the proportion…
  • 2020 American Transplant Congress

    A Hybrid Data Envelopment Analysis-Artificial Neural Network (DEANN) Technique for Extrapolating the Evolution of Kidney Transplant Patients

    F. Santos-Arteaga1, D. Di Caprio2, D. Cucchiari3, J. M. Campistol3, F. Oppenheimer3, F. Diekmann3, I. Revuelta3

    1Faculty of Economics and Management, Free University of Bolzano, Bolzano, Italy, 2Department of Economics and Management, University of Trento, Trento, Italy, 3Renal Transplant Unit, Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain

    *Purpose: The current study introduces a hybrid Data Envelopment Analysis (DEA) - Artificial Neural Network (ANN) technique to extrapolate the evolution of transplant patients based…
  • 2020 American Transplant Congress

    Safely Increasing the Number of Renal Transplants Performed in a Small Center Through the Use of Acute Kidney Injury Donors

    S. Batie1, K. Eid2, K. Gabrys3, F. Barrantes3, B. Trujillo2, H. Kerr2

    1Presbyterian Healthcare Services, University of New Mexico Health Sciences Center, Albuquerque, NM, 2Presbyterian Healthcare Services, Albuquerque, NM, 3Renal Medicine Associates, Presbyterian Healthcare Services, Albuquerque, NM

    *Purpose: New Mexico is medically underserved state with a significant end-stage renal disease population. This study aims to further demonstrate the safety of utilizing AKI…
  • 2020 American Transplant Congress

    Allograft Loss and Patient Death among Kidney Transplant Recipients; Is Therapy Non-Adherence the Underlying Perpetrator?

    K. Kalra, R. Munjal, A. Cherukuri, R. Mehta, C. Puttarajappa, D. Jorgensen, P. Sood, C. Wu, N. Shah, S. Hariharan

    Nephrology, University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: To ascertain causes of allograft dysfunction, loss and death in a cohort of kidney transplant patients*Methods: In this Retrospective cohort study, 943 patients who…
  • 2020 American Transplant Congress

    Donor Intervention and Recipient Treatment with Recombinant Human C1 Inhibitor Prevents Delayed Graft Function in a Non-Human Primate Model of Kidney Transplantation

    J. A. Reyes1, C. Blanton1, M. Eerhart1, P. Chlebeck1, M. Springer1, Y. Ponstein2, E. van Amersfoort2, J. Torrealba3, Y. Yankol1, A. D'Allessandro1, L. Fernandez1

    1Surgery, University of Wisconsin, Madison, WI, 2Pharming Technologies BV, Leiden, Netherlands, 3Pathology, UT Soutwestern, Dallas, TX

    *Purpose: There is currently no FDA-approved treatment to prevent delayed graft function (DGF) in kidney transplantation. We have shown that donor or recipient treatment with…
  • 2020 American Transplant Congress

    Paired-Donor Kidney Exchange Has Comparable Early Graft Function to Directed Living Donor

    E. McCracken, A. Sites, B. Rawashdeh, A. Nishio-Lucar, A. Agarwal

    Transplant Surgery, University of Virginia, Charlottesville, VA

    *Purpose: Living kidney donation in the United States is associated with improved graft and patient survival. However, there is minimal data on graft function in…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 64
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences